Enno Spillner
-
Extbase Variable Dump'distribution:BiomSpeaker.html' (29 chars)
-
Extbase Variable Dump'fileadmin/Webdata/Uploads/Veranstaltungen/2025/BayOConnect_2025/Speaker/Spil
lner_300x300.jpg' (92 chars) -
Extbase Variable Dump'Enno Spillner' (13 chars)
-
Extbase Variable Dump'Chief Financial Officer, Formycon' (33 chars)
-
Extbase Variable Dump'Enno Spillner started his career at MediaPlus (ServicePlan Group) in 1997 as
assistant to the Chief Executive Officer (CEO). In 1999, he joined Bioᴹ, as
Head of Finance & Controlling. Later on, he gained additional responsibilit
y for significant parts of the Bioᴹ investment business and in 2021 also joi
ned the management of the Bioᴹ VC Fund as a co-founder and partner. In this
context, he held interim positions as Chief Financial Officer (CFO) or Chief
Executive Officer (CEO) in selected portfolio companies. Subsequently, he w
orked for more than ten years (2005-2016) at the publicly listed 4SC AG, a b
iopharmaceutical company, where he held the position as Chief Financial Offi
cer (CFO) and later additionally as Chief Executive Officer (CEO). From 2016
to 2023, Enno Spillner served as member of the management board and Chief F
inancial Officer (CFO) of Evotec SE, which is listed on the Frankfurt Stock
Exchange (Prime Standard) as well as NASDAQ. In his role as Chief Financial
Officer (CFO), he was responsible in particular for the company's successful
capital market positioning and various successful financial and M&A transac
tions, and led the company to the U.S. technology exchange NASDAQ in 2021. S
ince April 2023, he is Chief Financial Officer (CFO) of Formycon. In Novembe
r 2024, he successfully led the company into the Prime Standard of the Frank
furt Stock Exchange.' (1388 chars)